Neutropenia News and Research

RSS
Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils, the most important type of white blood cell, in the blood.
Australian program helps keep young cancer patients with a fever at home

Australian program helps keep young cancer patients with a fever at home

Newer data confirms survival advantages, but also side effects for ribociclib in breast cancer

Newer data confirms survival advantages, but also side effects for ribociclib in breast cancer

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

Adoptive T-cell therapy targeting MAGE-A4 achieves responses in patients with multiple solid tumors

New strategy identified to address the underlying cause of LAD1 patients' symptoms

New strategy identified to address the underlying cause of LAD1 patients' symptoms

Children with COVID-19 presenting with sudden severe lung disease

Children with COVID-19 presenting with sudden severe lung disease

Study creates a new platform to study single-cell genomics of many diseases

Study creates a new platform to study single-cell genomics of many diseases

Majority of patients with mantle cell lymphoma may benefit from CAR T-cell therapy KTE-X19

Majority of patients with mantle cell lymphoma may benefit from CAR T-cell therapy KTE-X19

Wayne State researchers receive grant to develop new treatments for Barth syndrome

Wayne State researchers receive grant to develop new treatments for Barth syndrome

New way to treat stroke using an already FDA-approved drug shows promise

New way to treat stroke using an already FDA-approved drug shows promise

Novel drug shows efficacy against advanced ROS1 and NTRK fusion-positive NSCLC

Novel drug shows efficacy against advanced ROS1 and NTRK fusion-positive NSCLC

Study shows safety of palbociclib for advanced breast cancer patients with unique gene alteration

Study shows safety of palbociclib for advanced breast cancer patients with unique gene alteration

FDA approves first therapy for symptomatic tenosynovial giant cell tumor

FDA approves first therapy for symptomatic tenosynovial giant cell tumor

FDA grants accelerated approval to new treatment for refractory multiple myeloma

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Making Bacterial Infections a Thing of the Past for Chronic Respiratory Conditions

Making Bacterial Infections a Thing of the Past for Chronic Respiratory Conditions

Investigational drug for treatment of sickle cell disease shows early promise in clinical trials

Investigational drug for treatment of sickle cell disease shows early promise in clinical trials

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Targeted therapy plus hormone therapy improves survival in premenopausal patients with advanced HR+ breast cancer

Targeted therapy plus hormone therapy improves survival in premenopausal patients with advanced HR+ breast cancer

FDA extends indication of metastatic breast cancer treatment to include male patients

FDA extends indication of metastatic breast cancer treatment to include male patients

Best proven drug to treat schizophrenia could be safely given to African descent people

Best proven drug to treat schizophrenia could be safely given to African descent people

When genomic sequencing fails to diagnose a rare disease

When genomic sequencing fails to diagnose a rare disease